The Lockwood Group
The Lockwood Group is a private, Ares Management-owned healthcare services platform operating through seven subsidiaries that deliver medical communications, accredited oncology education, scientific animation, and market access consulting to pharmaceutical, biotechnology, and medical device clients.
- Company typePrivate
- Founded2007
- HeadquartersStamford, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What The Lockwood Group does
The Lockwood Group is a privately held, Ares Management-owned healthcare services platform headquartered in Stamford, Connecticut, operating through a network of seven wholly owned subsidiaries: Lockwood Medical Communications (core medcomms agency), Random42 (London-based scientific animation and XR studio), Nexus Health (market access consulting), IDEOlogy Health (omnichannel medical education), Research To Practice (oncology and hematology continuing medical education), Total Health (live and virtual oncology conferences), and Stratis Group (commercialization analytics). Founded in 2007, the company employs more than 800 professionals, including over 150 PhDs, MDs, and experienced medical writers covering 100+ disease states, and reports operational scale including 150+ product launches, support for 100+ oncology brands, and 300+ hours of accredited oncology education content.
The company serves three primary customer segments: pharmaceutical, biotechnology, and medical device companies that purchase strategic medical communications, publications, medical affairs, market access, and scientific visualization services on a project-quote basis; oncology and hematology healthcare professionals who receive free accredited CME/NCPD education through RTP and Total Health; and rare disease companies served through a specialized Lockwood Rare Disease sub-brand. Revenue is generated entirely through professional services engagements (no disclosed self-serve or productized pricing), with educational content distributed freemium to clinicians to build engagement reach that, in turn, supports paid pharma-sponsored programs and KOL engagement.
Technology underpins service delivery rather than being sold standalone. The proprietary Lockwood Intelligence platform applies AI-enabled capabilities to content enhancement, literature review, HCP engagement intelligence, and congress coverage; the AIMED Method uses non-generative AI for visual performance optimization of medical posters and slides; and the SiMPL Method supports health literacy improvements in patient materials. Distribution combines direct enterprise sales teams serving pharma/biotech accounts with self-serve digital education platforms and 60+ live and virtual programs annually. The company's growth strategy has been predominantly inorganic, with five completed acquisitions since 2022 accelerating capability expansion across medical education, market access, and scientific animation.
The Lockwood Group firmographics
Firmographics- Name
- The Lockwood Group
- Legal name
- The Lockwood Group
- Website
- https://thelockwoodgrp.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- The Lockwood Group is a private, Ares Management-owned healthcare services platform operating through seven subsidiaries that deliver medical communications, accredited oncology education, scientific animation, and market access consulting to pharmaceutical, biotechnology, and medical device clients.
- Ownership category
- akta.pro rank
The Lockwood Group industry classification
Industry- Product category
- Healthcare Services / Medical Communications
- NAICS
- Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
- akta.pro secondary industry
- Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)
Keywords
Where The Lockwood Group is headquartered
LocationHeadquarters
- HQ city
- Stamford
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
The Lockwood Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Communications Services: Professional services revenue from medical affairs, publications, and commercial marketing services for pharmaceutical and biotech clients. Services include strategic consulting, content development, KOL engagement, and regulatory support.
- Medical Education Services: Accredited continuing medical education (CME) and professional education programs for healthcare providers in oncology and hematology. Delivered through live symposia, virtual events, digital content, and conferences.
- Scientific Animation and Visualization: Custom scientific animation, extended reality (XR), and interactive experiences for pharmaceutical companies to communicate complex scientific concepts and drug mechanisms.
- Market Access Consulting: Strategic consulting for product launch, pricing, contracting, patient services, evidence planning, and value communication for life sciences companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free oncology education for healthcare professionals |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
The Lockwood Group product offering
Product offeringCore offering
The Lockwood Group is a healthcare services platform that delivers integrated medical communications, scientific animation, medical education, and market access consulting to pharmaceutical, biotech, and medical device companies. Operating through specialized subsidiaries (Lockwood Medical Communications, Random42, IDEOlogy Health, Research To Practice, Total Health, and Nexus Health), the company provides strategy, content, scientific publications, medical affairs, KOL engagement, regulatory consulting, and accredited oncology education to help life sciences clients accelerate product readiness and commercialization.
Differentiator
Problem solved
Functional benefit
Brands
- Lockwood Intelligence: AI-enabled platform offering content enhancement, insight gathering, congress coverage enhancement, literature review analysis, HCP management and engagement intelligence, landscape analysis intelligence, and community oncology intelligence.
- The AIMED Method
- The SiMPL Method
- IDEO Talks
- Sound Bites
Products and services
- Lockwood Medical Communications Medical communications agency delivering strategic scientific content, scientific publications, medical affairs solutions, and commercial marketing support. Functions as an extension of pharmaceutical, biotech, and medical device client teams to provide strategy, content, and experiences that drive better patient care outcomes.
- Random42 Scientific Animation Scientific animation studio where scientists, artists, animators, and programmers create immersive medical animations, extended reality (XR) experiences, and interactive content for scientific storytelling. Produces impactful scientific imagery, MOA/MOD animations, video abstracts, and interactive assets for pharmaceutical industry clients.
- Nexus Health Market Access Market access entity providing integrated strategic consulting, value communications, pricing and contracting, patient services, evidence planning, data insights and analytics, and policy and advocacy support. Helps manufacturers optimize product launches and commercialization with deep scientific and market access expertise.
- IDEOlogy Health Medical Education Omnichannel non-promotional medical education company providing innovative engagement platforms (IDEO Talks and Sound Bites), strategic healthcare provider communications tools, and CE-accredited medical education conferences. Reaches approximately 30% of community oncologists in the United States.
- Research To Practice (RTP) Medical education company specializing in physician and allied health professional education focused exclusively on oncology and hematology. Provides over 300 hours of accredited education across multiple formats, designed to keep cancer care clinicians current with emerging clinical data and treatment strategies.
- Total Health Oncology Education Medical information company providing free oncology medical education for cancer care professionals through tailored content, courses, and conferences delivered in-person or virtually. Delivers 60+ programs annually across virtual and in-person formats to equip clinicians with latest strategies to improve clinical practice and treatment outcomes.
- Lockwood Biotech Bespoke biotech solutions providing custom-sized teams of scientists, launch strategists, and client service experts for prelaunch, launch, and post-launch support tailored to biotechnology company needs across multiple disease states.
- Lockwood Rare Disease Specialized rare disease medical communications services partnering with companies to bring hope to patients through awareness building, advocate cultivation, patient connection, and commitment demonstration. Covers 43 rare therapeutic areas with 16 rare disease brand launches within 5 years.
- Lockwood Oncology Specialized oncology expertise with 100 dedicated scientific directors having advanced training across more than 30 tumor types and 200 years of collective experience. Offers medical strategy, communications, education, medical information, and community engagement services for oncology brands.
- Research To Practice Digital Platform Digital oncology education platform providing accredited continuing medical education (CME), Maintenance of Certification (MOC/ABIM/ABS), and Nursing Continuing Professional Development (NCPD) credits. Features 300+ hours of content, 225+ activities, single sign-on, robust search, integrated certification, and mobile-first responsive design.
- Stratis Group Commercialization Consulting Consulting firm specializing in commercialization strategy, market access, and analytics for pharmaceutical, biotechnology, and physician network clients. Adds analytics-driven commercialization expertise to the Lockwood platform.
Quantifiable outcome
- Over 100 distinct oncology brands supported in 2 dozen disease states in past 5 years
- +3 more outcomes
Companies that use The Lockwood Group
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
The Lockwood Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability7 records
Feature4 records
The Lockwood Group partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Stratis GroupcoreStratis Group is a consulting firm specializing in commercialization strategy, market access, and analytics for pharmaceutical, biotechnology, and physician network clients. Acquired by Nexus Health to expand commercialization and market access capabilities.
- Total HealthcoreTotal Health is a leading provider of free oncology medical education for cancer care professionals. Delivers 60+ programs annually across virtual and in-person formats. Founded by Sarah Louden, Total Health expands The Lockwood Group's educational offerings.
- Research To Practice (RTP)coreResearch To Practice is a medical education company based in Miami, FL, specializing in physician and allied health professional education focused exclusively on oncology and hematology. Founded by medical oncologist Neil Love, MD, with 40+ years of experience.
- IDEOlogy HealthcoreIDEOlogy Health, based in Austin TX, is a best-in-class omnichannel medical education company known for innovative engagement platforms including IDEO Talks and Sound Bites. Acquisition strengthens The Lockwood Group's community oncology presence.
- Random42coreRandom42 is a scientific animation studio based in London, known for award-winning medical animations and immersive experiences. Now part of The Lockwood Group, it enhances scientific communication solutions for the pharmaceutical industry globally.
Scale indicators11 records
Recent moves7 records
Expansion highlights7 records
The Lockwood Group competitors and assessment
Company assessmentDirect peers
- PRECISIONscientia: Specialized medical affairs and scientific communications agency serving pharma and biotech clients. Directly comparable to Lockwood Medical Communications on the medical affairs and publications side of Lockwood's portfolio.
- CMI/Compas: Healthcare media and communications agency focused on HCP engagement and pharma marketing. Closely aligned with Lockwood's commercial marketing, KOL engagement, and medical communications offerings.
- Fingerpaint: Independent healthcare marketing and communications agency combining advertising, medical communications, and analytics. Highly comparable to Lockwood's integrated communications and commercialization positioning.
- MedThink Communications: Medical communications and healthcare marketing agency with strong promotional and non-promotional capabilities. Directly comparable across Lockwood's medical affairs and commercial marketing segments.
- Trinity Life Sciences: Life sciences strategic consulting firm specializing in market access, commercialization, and evidence generation. Closely comparable to Nexus Health and Stratis Group within the Lockwood platform.
Broad incumbents
- Havas Health & You: Global healthcare communications network within Havas offering brand, medical, and digital communications across pharma. Wider portfolio than Lockwood but overlapping medical communications capabilities.
- Publicis Health: Global healthcare communications network within Publicis offering medical affairs, advertising, and patient engagement. Competes with Lockwood across medical communications with broader scale.
- Omnicom Health Group: Healthcare communications holding group within Omnicom offering medical education, advertising, and PR. Competes with Lockwood across the medical communications value chain with broader service breadth.
- Syneos Health: Large biopharmaceutical services organization combining clinical development and commercialization services. Overlaps with Lockwood's market access and medical communications segments as part of a broader CRO offering.
Emerging players
- Real Chemistry: Healthcare marketing and communications firm combining data, creative, and media capabilities. Comparable to Lockwood's integrated communications and analytics-driven engagement offerings with a more digital-native orientation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
The Lockwood Group social profiles
Digital presenceThe Lockwood Group compliance and trust
Trust signalCompliance5 records
The Lockwood Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Lockwood Group leadership team
Management profileNumber of profiles
Profiles4 records
The Lockwood Group subsidiaries and ownership
Company hierarchySubsidiaries10 records
The Lockwood Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Lockwood Group M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Lockwood Group
What does The Lockwood Group do?
The Lockwood Group is a healthcare services platform that delivers integrated medical communications, scientific animation, medical education, and market access consulting to pharmaceutical, biotech, and medical device companies. Operating through specialized subsidiaries (Lockwood Medical Communications, Random42, IDEOlogy Health, Research To Practice, Total Health, and Nexus Health), the company provides strategy, content, scientific publications, medical affairs, KOL engagement, regulatory consulting, and accredited oncology education to help life sciences clients accelerate product readiness and commercialization.
Is The Lockwood Group a public or private company?
The Lockwood Group is a private company. It is classified as private equity controlled and is currently operating.
When was The Lockwood Group founded?
The Lockwood Group was founded in 2007. It employs 501 to 1,000 people.
Where is The Lockwood Group based?
The Lockwood Group is headquartered in Stamford, United States, in the North America region.
How does The Lockwood Group make money?
Four revenue lines are on record. Medical Communications Services are the primary driver. The others are medical Education Services, scientific Animation and Visualization and market Access Consulting.
Who are The Lockwood Group's main competitors?
Direct peers on record are PRECISIONscientia, CMI/Compas, Fingerpaint, MedThink Communications and Trinity Life Sciences. Broad incumbents are Havas Health & You, Publicis Health, Omnicom Health Group and Syneos Health. Real Chemistry is listed as an emerging player.
Does The Lockwood Group have an API?
No public API is recorded for The Lockwood Group.
What industry is The Lockwood Group in?
The Lockwood Group's product category is Healthcare Services / Medical Communications. Its primary akta.pro industry code is HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP, with a secondary code of HLAGAJAL, Regulatory Information Management (RIM) & Submission Publishing Software. Its NAICS code is 54169 and its SIC code is 8731.